Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-low-dose naloxone added to fentanyl-lidocaine peribulbar anesthesia for cataract surgery
ACTRN12614000545662Phase 4Completed
- Sponsor
- Hoda Alsaid Ahmed Ezz
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cataract comparing Active control: fentanyl + lidocaine + hyaluronidase with naloxone + fentanyl + lidocaine + hyaluronidase (2 arms). Primary endpoint: Duration of analgesia. Started May 2013; status: completed.
02
Drugs
naloxonefentanyllidocainehyaluronidase
03
Conditions
cataract
Beyond the preview
Go deeper on ACTRN12614000545662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000545662.